Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer.
Ciscar M, Trinidad EM, Perez-Chacon G, Alsaleem M, Jimenez M, Jimenez-Santos MJ, Perez-Montoyo H, Sanz-Moreno A, Vethencourt A, Toss M, Petit A, Soler-Monso MT, Lopez V, Gomez-Miragaya J, Gomez-Aleza C, Dobrolecki LE, Lewis MT, Bruna A, Mouron S, Quintela-Fandino M, Al-Shahrour F, Martinez-Aranda A, Sierra A, Green AR, Rakha E, Gonzalez-Suarez E. Ciscar M, et al. Among authors: jimenez santos mj. EMBO Mol Med. 2023 Apr 11;15(4):e16715. doi: 10.15252/emmm.202216715. Epub 2023 Mar 7. EMBO Mol Med. 2023. PMID: 36880458 Free PMC article.
bollito: a flexible pipeline for comprehensive single-cell RNA-seq analyses.
García-Jimeno L, Fustero-Torre C, Jiménez-Santos MJ, Gómez-López G, Di Domenico T, Al-Shahrour F. García-Jimeno L, et al. Among authors: jimenez santos mj. Bioinformatics. 2022 Jan 27;38(4):1155-1156. doi: 10.1093/bioinformatics/btab758. Bioinformatics. 2022. PMID: 34788788
Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data.
Fustero-Torre C, Jiménez-Santos MJ, García-Martín S, Carretero-Puche C, García-Jimeno L, Ivanchuk V, Di Domenico T, Gómez-López G, Al-Shahrour F. Fustero-Torre C, et al. Among authors: jimenez santos mj. Genome Med. 2021 Dec 16;13(1):187. doi: 10.1186/s13073-021-01001-x. Genome Med. 2021. PMID: 34911571 Free PMC article.
Bioinformatics roadmap for therapy selection in cancer genomics.
Jiménez-Santos MJ, García-Martín S, Fustero-Torre C, Di Domenico T, Gómez-López G, Al-Shahrour F. Jiménez-Santos MJ, et al. Mol Oncol. 2022 Nov;16(21):3881-3908. doi: 10.1002/1878-0261.13286. Epub 2022 Aug 20. Mol Oncol. 2022. PMID: 35811332 Free PMC article. Review.
CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response.
Jutzi JS, Marneth AE, Jiménez-Santos MJ, Hem J, Guerra-Moreno A, Rolles B, Bhatt S, Myers SA, Carr SA, Hong Y, Pozdnyakova O, van Galen P, Al-Shahrour F, Nam AS, Mullally A. Jutzi JS, et al. Among authors: jimenez santos mj. Leukemia. 2023 Feb;37(2):359-369. doi: 10.1038/s41375-022-01781-0. Epub 2022 Dec 6. Leukemia. 2023. PMID: 36473980
PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data.
Jiménez-Santos MJ, Nogueira-Rodríguez A, Piñeiro-Yáñez E, López-Fernández H, García-Martín S, Gómez-Plana P, Reboiro-Jato M, Gómez-López G, Glez-Peña D, Al-Shahrour F. Jiménez-Santos MJ, et al. Nucleic Acids Res. 2023 Jul 5;51(W1):W411-W418. doi: 10.1093/nar/gkad412. Nucleic Acids Res. 2023. PMID: 37207338 Free PMC article.
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.
Jutzi JS, Marneth AE, Ciboddo M, Guerra-Moreno A, Jiménez-Santos MJ, Kosmidou A, Dressman JW, Liang H, Hamel R, Lozano P, Rumi E, Doench JG, Gotlib J, Krishnan A, Elf S, Al-Shahrour F, Mullally A. Jutzi JS, et al. Among authors: jimenez santos mj. Blood. 2022 Sep 15;140(11):1291-1304. doi: 10.1182/blood.2022015629. Blood. 2022. PMID: 35763665 Free PMC article.